ARJOBS Stock Overview
Develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Arjo AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 36.40 |
| 52 Week High | SEK 47.36 |
| 52 Week Low | SEK 35.33 |
| Beta | 0.40 |
| 1 Month Change | -0.22% |
| 3 Month Change | n/a |
| 1 Year Change | -11.50% |
| 3 Year Change | -61.18% |
| 5 Year Change | -23.24% |
| Change since IPO | 46.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| ARJOBS | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.4% | 0.3% |
| 1Y | -11.5% | -8.0% | 6.6% |
Return vs Industry: ARJOBS underperformed the UK Medical Equipment industry which returned -8% over the past year.
Return vs Market: ARJOBS underperformed the UK Market which returned 6.6% over the past year.
Price Volatility
| ARJOBS volatility | |
|---|---|
| ARJOBS Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.7% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: ARJOBS's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine ARJOBS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 6,500 | Joacim Lindoff | www.arjo.com/int/ |
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions.
Arjo AB (publ) Fundamentals Summary
| ARJOBS fundamental statistics | |
|---|---|
| Market cap | SEK 10.04b |
| Earnings (TTM) | SEK 505.00m |
| Revenue (TTM) | SEK 11.18b |
19.9x
P/E Ratio0.9x
P/S RatioIs ARJOBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARJOBS income statement (TTM) | |
|---|---|
| Revenue | SEK 11.18b |
| Cost of Revenue | SEK 6.31b |
| Gross Profit | SEK 4.87b |
| Other Expenses | SEK 4.37b |
| Earnings | SEK 505.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | 1.85 |
| Gross Margin | 43.59% |
| Net Profit Margin | 4.52% |
| Debt/Equity Ratio | 53.3% |
How did ARJOBS perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield49%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 18:11 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Arjo AB (publ) is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sten Gustafsson | ABG Sundal Collier |
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Karl Norén | Danske Bank |